Shadi Tabibian: Beyond Bleeding – Women Living with von Willebrand Disease
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn about a recent article by Rezan Abdul-Kadir et al., published in Haematologica, adding:
“Women with von Willebrand disease have been overlooked for far too long.
Heavy menstrual bleeding is often the first clinical manifestation of von Willebrand disease (VWD), yet diagnosis is frequently delayed for years, resulting in preventable iron deficiency, impaired quality of life, and avoidable obstetric complications.
This outstanding review by Abdul-Kadir and Ragni highlights a crucial shift in perspective: VWD in women is not simply a bleeding disorder-it is a lifelong reproductive health challenge that requires coordinated hematology and gynecology care.
Key clinical takeaways:
- Heavy menstrual bleeding should always prompt evaluation for an underlying bleeding disorder.
- Routine assessment of iron deficiency is essential, yet remains significantly underutilized.
- Management should be individualized, combining hormonal and hemostatic therapies according to disease severity and reproductive goals.
- Pregnancy and the postpartum period require proactive multidisciplinary planning, particularly for women with severe VWD.
- Future progress depends on stronger evidence, inclusion of women in clinical trials, and truly patient-centered care.
As hematologists and laboratory professionals, we should recognize that early diagnosis, comprehensive iron assessment, and collaboration across specialties can profoundly improve outcomes for girls and women living with VWD.
Congratulations to the authors for this comprehensive and timely review.”
Title: Gynecologic and obstetric management of girls and women with von Willebrand disease
Authors: Rezan Abdul-Kadir, Margaret V. Ragni

Other posts featuring Shadi Tabibian on Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders